SYNGENE

SYNGENE INTERNATIONAL

Large Cap BSE: 539268 NSE: SYNGENE
₹591.7
9.15 (1.57%)
As on 12 August, 2022 | 18:25

Syngene International Share Price

Syngene International Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Syngene International Share Returns

  • Over 1 Month 3.65%
  • Over 3 Month 9.8%
  • Over 6 Month 0.66%
  • Over 1 Year -4.92%

Syngene International Key Statistics

P/E Ratio 60.5
PEG Ratio -8.1
Market Cap Cr 23,753
Price to Book Ratio 7.2
EPS 10.4
Dividend 0.2
Relative Strength Index 58.02
Money Flow Index 42.5
MACD Signal 1.35
Average True Range 16.79

Syngene International Investment Rating

  • Master Rating:
  • Syngene Inter has an operating revenue of Rs. 2,654.20 Cr. on a trailing 12-month basis. An annual revenue growth of 18% is outstanding, Pre-tax margin of 19% is great, ROE of 12% is good. The company has a reasonable debt to equity of 16%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its key moving averages, around 3% and 0% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 14% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 60 which is a FAIR score but needs to improve its earnings, a RS Rating of 49 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 63 indicates it belongs to a poor industry group of Medical-Research Eqp/Svc and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Syngene International Financials
  • Indicator
  • Jun 2022
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev Qtr Cr
  • 645
  • 759
  • 640
  • 610
  • 594
  • 658
  • Operating Expenses Qtr Cr
  • 473
  • 509
  • 437
  • 432
  • 429
  • 443
  • Operating Profit Qtr Cr
  • 172
  • 249
  • 203
  • 177
  • 164
  • 215
  • Depreciation Qtr Cr
  • 86
  • 80
  • 79
  • 76
  • 75
  • 70
  • Interest Qtr Cr
  • 9
  • 6
  • 9
  • 1
  • 8
  • 7
  • Tax Qtr Cr
  • 19
  • 31
  • 24
  • 15
  • 17
  • 32
  • Net Profit Qtr Cr
  • 73
  • 147
  • 103
  • 67
  • 77
  • 161

Syngene International Technicals

EMA & SMA

Current Price
591.7
9.15 (1.57%)
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 576.19
  • 50 Day
  • 572.65
  • 100 Day
  • 574.01
  • 200 Day
  • 579.54
  • 20 Day
  • 582.1
  • 50 Day
  • 565.45
  • 100 Day
  • 577.51
  • 200 Day
  • 579.57

Syngene International Resistance and Support

PIVOT
₹582.37
Resistance
  • First Resistance
  • 587.84
  • Second Resistance
  • 593.12
  • Third Resistance
  • 598.59
Support
  • First Resistance
  • 577.09
  • Second Resistance
  • 571.62
  • Third Resistance
  • 566.34
  • RSI
  • 58.02
  • MFI
  • 42.5
  • MACD Single Line
  • 1.35
  • MACD
  • 1.9

Syngene International Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • 386,580
  • 15,699,014
  • 40.61
  • Week
  • 377,509
  • 15,243,793
  • 40.38
  • 1 Month
  • 735,123
  • 22,075,738
  • 30.03
  • 6 Month
  • 461,585
  • 18,149,503
  • 39.32

Syngene International Result Highlights

Syngene International Synopsis

NSE-Medical-Research Eqp/Svc

Syngene Internationa is involved in the business activities of Scientific research and development. Company’s Total Operating Revenue is Rs. 2601.40 Cr. and Equity Capital is Rs. 400.80 Cr. for the Year ended 31/03/2022. Syngene International Ltd. is a Public Limited Listed company incorporated on 18/11/1993 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L85110KA1993PLC014937 and registration number is 014937.
  • Market Cap
  • 23,575
  • Sales
  • 2,652
  • Shares in Float
  • 12.04
  • No of funds
  • 215
  • Yield
  • 0.09
  • Book Value
  • 7.09
  • U/D Vol ratio
  • 1
  • LTDebt / Equity
  • 16
  • Alpha
  • -0.04
  • Beta
  • 0.84

Syngene International

  • Owner Name
  • Jun-22
  • Mar-22
  • Dec-21
  • Sep-21
  • Promoters
  • 70.29%
  • 70.41%
  • 70.41%
  • Mutual Funds
  • 2.79%
  • 3.26%
  • 3.64%
  • Foreign Portfolio Investors
  • 14.12%
  • 13.67%
  • 13.82%
  • Financial Institutions/ Banks
  • Individual Investors
  • 9.03%
  • 9.22%
  • 9.19%
  • Others
  • 3.77%
  • 3.44%
  • 2.94%

Syngene International Management

  • Name
  • Designation
  • Ms. Kiran Mazumdar Shaw
  • Non Executive Chairman
  • Mr. Jonathan Hunt
  • Managing Director & CEO
  • Prof. Catherine Rosenberg
  • Non Executive Director
  • Ms. Vinita Bali
  • Lead Independent Director
  • Dr. Vijay Kuchroo
  • Independent Director
  • Dr. Carl Decicco
  • Independent Director
  • Ms. Sharmila Abhay Karve
  • Independent Director
  • Dr. Kush Parmar
  • Independent Director
  • Mr. Paul Blackburn
  • Independent Director

Syngene International Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Syngene International Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-07-20
  • Quarterly Results
  • 2022-04-27
  • Audited Results & Final Dividend
  • 2022-01-19
  • Quarterly Results
  • 2021-10-20
  • Quarterly Results
  • 2021-07-20
  • Quarterly Results
  • Date
  • Purpose
  • Remarks
  • 2022-07-01
  • FINAL
  • Rs.0.50 per share(5%)Final Dividend
  • 2022-07-01
  • SPECIAL
  • Rs.0.50 per share(5%)Special Dividend

Syngene International MF Shareholding

  • Name
  • Amount(cr)
  • UTI Flexi Cap Fund Regular Plan Growth
  • 25448
  • Kotak Equity Arbitrage Fund Growth
  • 24543
  • Nippon India Arbitrage Fund Growth
  • 10295
  • Mirae Asset Focused Fund Regular Growth
  • 8696
  • SBI Arbitrage Opportunities Fund Regular Growth
  • 7545

Syngene International FAQs

What is Share Price of Syngene International ?

Syngene International share price is ₹591 As on 12 August, 2022 | 18:11

What is the Market Cap of Syngene International ?

The Market Cap of Syngene International is ₹23752.9 Cr As on 12 August, 2022 | 18:11

What is the P/E ratio of Syngene International ?

The P/E ratio of Syngene International is 60.5 As on 12 August, 2022 | 18:11

What is the PB ratio of Syngene International ?

The PB ratio of Syngene International is 7.2 As on 12 August, 2022 | 18:11

Q1FY23